DGAP-News
CannaVest Corp. and PhytoSphere Systems Featured on NBC 7 News - Seite 2
Medical Marijuana Conference 'Green Cup' contest - all for Highest CBD
Concentrate.
In addition to CBD Simple(tm), the company is responsible for developing CBD-rich
hemp oil products including Real Scientific Hemp Oil (RSHO)(tm), the highest
quality, all-natural, super concentrated CBD nutritional supplement on the
market today; Cibdex(tm), an everyday CBD-rich hemp oil supplement available in
100mg and 500mg tinctures and 25mg vegan capsules; and Cibaderm(tm), a CBD-rich
hemp oil infused personal care line that includes first-of-its-kind hair care,
body care, lotions and salve.
About CannaVest Corp.
CannaVest Corp. is in the business of investing in and developing hemp-based
businesses. CannaVest Corp. also develops, produces, markets and sells
end-consumer products to the nutraceutical industry containing the hemp plant
extract, cannabidiol (CBD). Additionally, the company resells--to third
parties--raw product acquired by CannaVest Corp. pursuant to the company's
supply international relationships. CannaVest seeks to take advantage of an
emerging worldwide trend to re-energize the production of industrial hemp and
to foster its many uses for consumers. Cannabinoids (cannabidiol/CBD) are
natural constituents of the hemp plant, and CBD is derived from hemp stalk and
seed. Additional information is available from OTCMarkets.com or by visiting
CannaVest.com.
About PhytoSphere Systems
PhytoSphere Systems is a global phytocannabinoid biotechnology company based in
San Diego, California and a wholly-owned subsidiary of CannaVest Corp. (OTC:
CANV). The company utilizes advanced cultivation methods and state-of-the-art
processing technology leading to development of pharmaceutical, nutraceutical
and food products.
PhytoSphere Systems, the manufacturer of the CBD-rich hemp oil used in Real
Scientific Hemp Oil (RSHO), has developed special cultivars (similar to
'strains') that produce hemp that is especially rich in CBD, making it possible
for PhytoSPHERE to offer all-natural products with high concentrations of
hemp-based CBD. For more information, visit: PhytoSphereSystems.com
FOOD AND DRUG ADMINISTRATION (FDA) DISCLOSURE
These statements have not been evaluated by the FDA and are not intended to
diagnose, treat or cure any disease.
FORWARD-LOOKING DISCLAIMER
This press release may contain certain forward-looking statements and
information, as defined within the meaning of Section 27A of the Securities Act
of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject
to the Safe Harbor created by those sections. This material contains statements
businesses. CannaVest Corp. also develops, produces, markets and sells
end-consumer products to the nutraceutical industry containing the hemp plant
extract, cannabidiol (CBD). Additionally, the company resells--to third
parties--raw product acquired by CannaVest Corp. pursuant to the company's
supply international relationships. CannaVest seeks to take advantage of an
emerging worldwide trend to re-energize the production of industrial hemp and
to foster its many uses for consumers. Cannabinoids (cannabidiol/CBD) are
natural constituents of the hemp plant, and CBD is derived from hemp stalk and
seed. Additional information is available from OTCMarkets.com or by visiting
CannaVest.com.
About PhytoSphere Systems
PhytoSphere Systems is a global phytocannabinoid biotechnology company based in
San Diego, California and a wholly-owned subsidiary of CannaVest Corp. (OTC:
CANV). The company utilizes advanced cultivation methods and state-of-the-art
processing technology leading to development of pharmaceutical, nutraceutical
and food products.
PhytoSphere Systems, the manufacturer of the CBD-rich hemp oil used in Real
Scientific Hemp Oil (RSHO), has developed special cultivars (similar to
'strains') that produce hemp that is especially rich in CBD, making it possible
for PhytoSPHERE to offer all-natural products with high concentrations of
hemp-based CBD. For more information, visit: PhytoSphereSystems.com
FOOD AND DRUG ADMINISTRATION (FDA) DISCLOSURE
These statements have not been evaluated by the FDA and are not intended to
diagnose, treat or cure any disease.
FORWARD-LOOKING DISCLAIMER
This press release may contain certain forward-looking statements and
information, as defined within the meaning of Section 27A of the Securities Act
of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject
to the Safe Harbor created by those sections. This material contains statements
Aktuelle Themen
Weitere Artikel des Autors
1 im Artikel enthaltener WertIm Artikel enthaltene Werte